Quantbot Technologies LP Invests $616,000 in Transcat, Inc. $TRNS

Quantbot Technologies LP acquired a new stake in Transcat, Inc. (NASDAQ:TRNS) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 8,409 shares of the scientific and technical instruments company’s stock, valued at approximately $616,000. Quantbot Technologies LP owned 0.09% of Transcat as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Geode Capital Management LLC lifted its holdings in Transcat by 1.8% during the 2nd quarter. Geode Capital Management LLC now owns 223,202 shares of the scientific and technical instruments company’s stock worth $19,189,000 after buying an additional 4,030 shares in the last quarter. Atria Investments Inc acquired a new position in shares of Transcat in the second quarter worth $259,000. 4D Advisors LLC purchased a new stake in shares of Transcat during the second quarter worth $3,009,000. Envestnet Asset Management Inc. increased its position in shares of Transcat by 151.7% during the second quarter. Envestnet Asset Management Inc. now owns 40,818 shares of the scientific and technical instruments company’s stock worth $3,509,000 after acquiring an additional 24,602 shares during the period. Finally, PNC Financial Services Group Inc. raised its stake in shares of Transcat by 1,118.2% in the second quarter. PNC Financial Services Group Inc. now owns 1,072 shares of the scientific and technical instruments company’s stock valued at $92,000 after acquiring an additional 984 shares in the last quarter. Institutional investors and hedge funds own 98.34% of the company’s stock.

Analysts Set New Price Targets

TRNS has been the subject of a number of recent research reports. Zacks Research upgraded Transcat from a “strong sell” rating to a “hold” rating in a report on Wednesday, March 4th. Weiss Ratings restated a “sell (d+)” rating on shares of Transcat in a report on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Transcat presently has a consensus rating of “Moderate Buy” and an average target price of $105.33.

Transcat Trading Down 5.6%

Shares of NASDAQ:TRNS opened at $70.67 on Monday. Transcat, Inc. has a 52 week low of $50.23 and a 52 week high of $97.08. The company’s 50 day moving average is $68.54 and its two-hundred day moving average is $67.82. The company has a market cap of $659.35 million, a PE ratio of 83.14 and a beta of 0.71. The company has a current ratio of 2.21, a quick ratio of 1.85 and a debt-to-equity ratio of 0.34.

Transcat (NASDAQ:TRNS) last released its quarterly earnings data on Tuesday, February 3rd. The scientific and technical instruments company reported $0.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.30 by ($0.04). The firm had revenue of $83.86 million for the quarter, compared to analysts’ expectations of $80.99 million. Transcat had a return on equity of 6.15% and a net margin of 2.47%. Equities analysts predict that Transcat, Inc. will post 2.3 earnings per share for the current fiscal year.

Transcat Company Profile

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.